Solara Active Pharma Sciences Ltd
Solara Active | 541540
SOLARA - Share Price Chart
Stock Performance
Ratios
About Company
- Solara Active Pharma Sciences Limited was incorporated on February 23, 2017 to undertake business in manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients (APIs)
- The Company has 6 APIs manufacturing plants located in Ambernath, Mangalore, Mysuru, Puducherry, Vishakhapatnam, and Cuddalore with a capacity of over 2,580 kilo litres and two R&D Centres in Chennai and Bengaluru
- The Company offer rich basket of niche high-value products for global markets
- The Company has developed 80+ commercial APIs predominantly in anthelmintic, anti-malarias, anti-infective, neuromuscular insomnia and anti-psychotic hyperkalemia segments, among others
- These drugs primarily deal with anthelmintic, anti-malarias, beta blockers, muscle relaxants, novel oral anticoagulants, anti-infective and other niche segments
- The Company's manufacturing facilities enjoy regulatory approvals from the United States Food and Drug Administration (USFDA); European Directorate for the Quality of Medicines (EDQM); Korea Food & Drug Administration (KFDA) - South Korea; Euro Zone - Good Manufacturing Practice (EUGMP) - Danish, World Health Organization (WHO) - Geneva; Medicines and Healthcare products Regulatory Agency (MHRA); Federal Commission for the Protection against Sanitary Risk (Cofepris) - Mexico; Therapeutic Goods Administration (TGA) - Australia; Pharmaceuticals and Medical Devices Agency (PMDA) - Japan
- The Company acquired 100% of the equity shares of Strides Chemicals Private Limited and made it the wholly owned subsidiary of the Company effective from September 1, 2018
- During the year 2018-19, the Company's wholly owned subsidiary Strides Chemicals Private Limited amalgamated with the Company on December 20, 2019 and the merger was given effect in February, 2020
- The Company's new Greenfield plant situated at SEZ unit, Plot No
- :3B,3C,3D, Part 2 and 2A-1, APIIC APSEZ, Atchutapuram Village, Rambilli Mandal, Visakhapatnam - 531011, Andhra Pradesh, commenced commercial production in 2021
Ethics: Solara Active Pharma Sciences Ltd is flagged for
Adequate
The company demonstrates adequate ESG practices with room for improvement.
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
News
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Top Gainers
Top Losers
Group Stocks
Frequently Asked Questions
What is Share Price of Solara Active Pharma Sciences Ltd?
The current share price of Solara Active Pharma Sciences Ltd (Solara Active) is ₹646.95. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Solara Active Pharma Sciences Ltd?
The Price-to-Earnings (P/E) ratio of Solara Active Pharma Sciences Ltd is 646.95. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd has a 52-week high of ₹712.00 and a 52-week low of ₹422.00. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Solara Active Pharma Sciences Ltd?
The Earnings Per Share (EPS) of Solara Active Pharma Sciences Ltd is ₹0.89. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Solara Active Pharma Sciences Ltd?
Solara Active Pharma Sciences Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
